Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance.
about
Animal models of the polycystic ovary syndrome phenotypeSteroidogenic versus Metabolic Programming of Reproductive Neuroendocrine, Ovarian and Metabolic DysfunctionsAn imbalance between apoptosis and proliferation contributes to follicular persistence in polycystic ovaries in ratsDevelopmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheepDevelopmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep.Developmental programming: prenatal steroid excess disrupts key members of intraovarian steroidogenic pathway in sheep.Reproduction Symposium: developmental programming of reproductive and metabolic health.Developmental programming: gestational testosterone treatment alters fetal ovarian gene expression.Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal modelsDevelopmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.Developmental programming: prenatal testosterone excess disrupts anti-Müllerian hormone expression in preantral and antral follicles.Developmental programming: impact of prenatal testosterone excess on ovarian cell proliferation and apoptotic factors in sheep.Developmental Programming: Does Prenatal Steroid Excess Disrupt the Ovarian VEGF System in Sheep?Sheep models of polycystic ovary syndrome phenotype.Developmental programming: gestational bisphenol-A treatment alters trajectory of fetal ovarian gene expressionSexual dimorphism in activation of placental autophagy in obese women with evidence for fetal programming from a placenta-specific mouse model.Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming.Developmental programming: Impact of prenatal testosterone treatment and postnatal obesity on ovarian follicular dynamicsFetal sex-related dysregulation in testosterone production and their receptor expression in the human placenta with preeclampsia.Prenatal programming: adverse cardiac programming by gestational testosterone excess.Developmental programming: rescuing disruptions in preovulatory follicle growth and steroidogenesis from prenatal testosterone disruption.Developmental programming: postnatal estradiol amplifies ovarian follicular defects induced by fetal exposure to excess testosterone and dihydrotestosterone in sheep.Developmental reprogramming of reproductive and metabolic dysfunction in sheep: native steroids vs. environmental steroid receptor modulatorsEffect of maternal PCOS and PCOS-like phenotype on the offspring's health.Involvement of PAPP-A and IGFR1 in Cystic Ovarian Disease in Cattle.The influence of the antiandrogen 2-hydroxyflutamide on the androgen receptor expression in the porcine ovarian follicles - an in vitro study.Developmental Programming: Impact of Gestational Steroid and Metabolic Milieus on Mediators of Insulin Sensitivity in Prenatal Testosterone-Treated Female Sheep.Developmental Programming: Gestational Exposure to Excess Testosterone Alters Expression of Ovarian Matrix Metalloproteases and Their Target ProteinsOvarian Follicular Theca Cell Recruitment, Differentiation, and Impact on Fertility: 2017 Update.Masculinization of the distal tubular and external genitalia in female sheep with prenatal androgen exposure.Ovarian and Extra-Ovarian Mediators in the Development of Polycystic Ovary Syndrome
P2860
Q27024884-B806390F-5E5B-4802-BCFE-26D8DA9BB5A8Q28085006-5C05F135-6F37-4538-9650-94FDD0080A9DQ30488925-16A7EAFF-D377-49D7-8156-4B723026E8A1Q33593356-5F1250CB-4D37-495E-975F-FFB5D9FE1A7CQ33868816-465D6708-2A23-4988-853C-8870B3086BAEQ34068333-E2D5B4EB-34DB-4E0F-8FF9-DB5E5E7FCEC0Q34127494-68734378-F87C-4983-A035-04D55AF91CE2Q34225368-4ED85CE4-C8B3-45D5-B838-64C8264BD61DQ34244204-10F93484-9930-4E87-9BA2-EF94889DF27EQ35763642-CFCD2AEA-9E7F-4586-9531-877D4B2B72FDQ35798524-0D306FC0-0EBA-4315-898E-7F177B3AACE7Q36121632-D16A9C94-42B1-4A64-82FD-C2A8FA8FED7AQ36455236-1A511F09-DEEB-4EB5-BAED-513B90A472B9Q36597826-06E400EB-8E9F-413A-8447-0B83B6BD5F30Q36770973-7DA656F4-0E1B-43D9-9137-D358505D102FQ36862632-504B3102-EA4E-4843-BF44-927CAD1AD261Q36907318-B32FBFC5-F024-42FE-B3F2-08FCAF296AB9Q36915901-E06EF6C0-56B0-49F4-B1ED-58F03AC312FFQ37016826-A37C9340-26E1-41BF-916E-2DCA486EAEC7Q37027521-B81FBDE0-A93D-4D70-A470-53B5E2CD4C10Q37054725-D67A1E23-498D-4AF2-A859-0BE7D2264DA8Q37651333-73E66B71-2AC4-43CF-BCB6-77CC9F0B6519Q37673266-894F783C-AD9C-4FFA-8B31-EBA6D09B18C1Q38660078-416C5444-DBC4-4424-99DD-9C5FF0D955E8Q40882634-3B92682E-B992-485C-BF6C-DBD95FB052F8Q45350391-D4083473-021D-4E69-BF28-DF7FDAA50D8BQ47639232-275D1FBC-EC2A-448B-A216-44301374E0EBQ47826190-99DE57E9-0917-42C7-81BE-862E6727F107Q48510887-F24B85FA-BBDF-4FBF-9E54-A3DBF90D4B12Q51411639-FF65785C-1DFD-4BF9-BFA5-71E054808FDDQ57458409-B5D5E6EF-AA95-47DB-989B-96AE144EE95C
P2860
Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Developmental programming: pre ...... rian steroid receptor balance.
@en
Developmental programming: pre ...... rian steroid receptor balance.
@nl
type
label
Developmental programming: pre ...... rian steroid receptor balance.
@en
Developmental programming: pre ...... rian steroid receptor balance.
@nl
prefLabel
Developmental programming: pre ...... rian steroid receptor balance.
@en
Developmental programming: pre ...... rian steroid receptor balance.
@nl
P2860
P356
P1433
P1476
Developmental programming: pre ...... arian steroid receptor balance
@en
P2093
Hugo H Ortega
Natalia R Salvetti
P2860
P304
P356
10.1530/REP-08-0491
P577
2009-03-04T00:00:00Z